Skip to main content
. Author manuscript; available in PMC: 2015 Jan 17.
Published in final edited form as: Nat Commun. 2014 Jul 17;5:4421. doi: 10.1038/ncomms5421

Fig. 1.

Fig. 1

JZL184 increases 2-AG levels in maternal and embryonic brains. (a) Ex vivo activity-based protein profiling of brain-derived serine hydrolases in vehicle and JZL184 (40 mg/kg)- treated adult and fetal cortices. (b) Select 2-monoacyl glycerol and N-acyl amide levels in maternal and fetal brains correlatively measured after JZL184 treatment. Data were expressed as means ± s.e.m., n = 2/group (mothers), n = 6/group (fetuses); **p < 0.01, *p < 0.05 (Student’s t-test).